Drug Discovery Informatics Market by Function, Solution and End User - Global Forecast to 2022

  • ID: 4446957
  • Report
  • Region: Global
  • 117 Pages
  • Markets and Markets
1 of 6
The Global Drug Discovery Informatics Market is Expected to Reach USD 2.84 Billion in 2022 from USD 1.67 Billion in 2017 at a CAGR of 11.2%.

FEATURED COMPANIES

  • Certara
  • Gvk Biosciences
  • Infosys
  • Jubilant Life Sciences
  • Perkinelmer
  • Selvita
  • MORE

“The global drug discovery informatics market is projected to grow at a CAGR of 11.2%.”

Growth in the drug discovery informatics market is mainly driven by factors such as rising R&D expenditure across the globe, increasing focus on drug delivery, and the need to control drug discovery and development costs. Impending patent expiries and the growing biotechnology industry are also expected to provide a wide range of growth opportunities for players in the market. On the other hand, the scarcity of skilled professionals and the high pricing and setup cost of informatics software are both factors that are expected to limit market growth to a certain extent.

“The sequencing and target data analysis segment is expected to account for the largest share in 2017.”

On the basis of function, the drug discovery informatics market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the drug discovery informatics market. Factors such as the expansive application of informatics solutions in targeted analysis and the large amount of data generated during the drug discovery process are driving the growth of this segment.

“The software segment is expected to account for the largest share in 2017.”

On the basis of solution, the market is classified into software and services. In 2017, the software segment is expected to account for the largest share of the global drug discovery informatics market. The largest share of this segment is attributed to the fast and efficient management of data generated throughout the drug discovery process using discovery informatics software solutions.

“North America is expected to account for the largest share during the forecast period.”

By geography, North America is expected to account for the largest share of the drug discovery informatics market in 2017. Established pharmaceutical industry with the presence of leading pharmaceutical and biotechnology companies attributes to the largest share of North America. Europe is expected to account for the second-largest share of the drug discovery informatics market.

Break-up profile of primaries:

  • By Company Type- Tier 1-45%, Tier 2-34% and Tier 3-21%
  • By Designation-C-level-36%, D-level-40% and Others-24%
  • By Region-North America-40%, Europe-22%, Asia Pacific-30%, and RoW-8%

The key players operating in the drug discovery informatics market are IBM (US), Infosys (India), Schrodinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US).

Research Coverage:

The drug discovery informatics market in this report is segmented by function, solution, end user, and region. The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the drug discovery informatics market.

Reasons to buy this report:

  • The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on portfolios offered by the top players in the global drug discovery informatics market. The report analyzes the market by function, solution, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global drug discovery informatics market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for global discovery informatics products across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global drug discovery informatics market
  • Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global drug discovery informatics market
READ MORE
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Certara
  • Gvk Biosciences
  • Infosys
  • Jubilant Life Sciences
  • Perkinelmer
  • Selvita
  • MORE

1 Introduction
1.1 Objectives Of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered For the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.2 Market Size Estimation
2.3 Market Breakdown And Data Triangulation
2.4 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Drug Discovery Informatics: Market Overview
4.2 Asia Pacific Drug Discovery Informatics Market, By Function And End User
4.3 Drug Discovery Informatics Market, By Solution
4.4 Geographical Snapshot Of the Drug Discovery Informatics Market

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Rising R&D Expenditure
5.2.1.2 Increasing Focus On Drug Discovery
5.2.1.3 Need To Control Drug Discovery And Development Costs
5.2.2 Restraint
5.2.2.1 High Pricing And Setup Cost Of Informatics Software
5.2.3 Opportunities
5.2.3.1 Patent Expiry
5.2.3.2 Growing Biotechnology Industry
5.2.4 Challenge
5.2.4.1 Scarcity Of Skilled Professionals

6 Drug Discovery Informatics Market, By Function
6.1 Introduction
6.2 Sequencing & Target Data Analysis
6.3 Docking
6.4 Molecular Modelling
6.5 Libraries & Database Preparation
6.6 Other Functions

7 Drug Discovery Informatics Market, By Solution
7.1 Introduction
7.2 Software
7.3 Services

8 Drug Discovery Informatics Market, By End User
8.1 Introduction
8.2 Pharmaceutical And Biotechnology Companies
8.3 Contract Research Organizations (Cros)
8.4 Other End Users

9 Drug Discovery Informatics Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 Rest Of Europe
9.4 Asia Pacific (APAC)
9.5 Rest Of the World

10 Competitive Landscape
10.1 Overview
10.2 Ranking Of Players, 2016
10.3 Competitive Scenario
10.3.1 Collaborations, Partnerships, Agreements, & Acquisitions
10.3.2 Expansions
10.3.3 Product Launches & Enhancements

11 Company Profiles
(Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*
11.1 Jubilant Life Sciences
11.2 Ibm
11.3 Infosys
11.4 Thermo Fisher Scientific
11.5 Perkinelmer
11.6 Schrödinger
11.7 Dassault Systèmes
11.8 Charles River Laboratories
11.9 Selvita
11.10 Certara
11.11 Gvk Biosciences
11.12 Collaborative Drug Discovery
11.13 Openeye Scientific Software
11.14 Io Informatics
11.15 Novo Informatics
*Details On Marketsandmarkets View, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, And Recent Developments Might Not Be Captured in Case Of Unlisted Companies.

12 Appendix
12.1 Insights Of Industry Experts
12.2 Discussion Guide
12.3 Knowledge Store: Subscription Portal
12.4 Introducing Rt: Real-Time Market Intelligence
12.5 Available Customizations
12.6 Related Reports
12.7 Author Details

List of Tables
Table 1 Drug Discovery Informatics Market, By Function, 2015-2022 (USD Million)
Table 2 Drug Discovery Informatics Market For Sequencing & Target Data Analysis, By Region, 2015-2022 (USD Million)
Table 3 North America: Drug Discovery Informatics Market For Sequencing & Target Data Analysis, By Country, 2015-2022 (USD Million)
Table 4 Europe: Drug Discovery Informatics Market For Sequencing & Target Data Analysis, By Country, 2015-2022 (USD Million)
Table 5 Drug Discovery Informatics Market For Docking, By Region, 2015-2022 (USD Million)
Table 6 North America: Drug Discovery Informatics Market For Docking, By Country, 2015-2022 (USD Million)
Table 7 Europe: Drug Discovery Informatics Market For Docking, By Country, 2015-2022 (USD Million)
Table 8 Drug Discovery Informatics Market For Molecular Modelling, By Region, 2015-2022 (USD Million)
Table 9 North America: Drug Discovery Informatics Market For Molecular Modelling, By Country, 2015-2022 (USD Million)
Table 10 Europe: Drug Discovery Informatics Market For Molecular Modelling, By Country, 2015-2022 (USD Million)
Table 11 Drug Discovery Informatics Market For Libraries & Database Preparation, By Region, 2015-2022 (USD Million)
Table 12 North America: Drug Discovery Informatics Market For Libraries & Database Preparation, By Country, 2015-2022 (USD Million)
Table 13 Europe: Drug Discovery Informatics Market For Libraries & Database Preparation, By Country, 2015-2022 (USD Million)
Table 14 Drug Discovery Informatics Market For Other Functions, By Region, 2015-2022 (USD Million)
Table 15 North America: Drug Discovery Informatics Market For Other Functions, By Country, 2015-2022 (USD Million)
Table 16 Europe: Drug Discovery Informatics Market For Other Functions, By Country, 2015-2022 (USD Million)
Table 17 Drug Discovery Informatics Market, By Solution, 2015-2022 (USD Million)
Table 18 Drug Discovery Informatics Market For Software, By Region, 2015-2022 (USD Million)
Table 19 North America: Drug Discovery Informatics Market For Software, By Country, 2015-2022 (USD Million)
Table 20 Europe: Drug Discovery Informatics Market For Software, By Country, 2015-2022 (USD Million)
Table 21 Drug Discovery Informatics Market For Services, By Region, 2015-2022 (USD Million)
Table 22 North America: Drug Discovery Informatics Market For Services, By Country, 2015-2022 (USD Million)
Table 23 Europe: Drug Discovery Informatics Market For Services, By Country, 2015-2022 (USD Million)
Table 24 Drug Discovery Informatics Market, By End User, 2015-2022 (USD Million)
Table 25 Drug Discovery Informatics Market For Pharmaceutical And Biotechnology Companies, By Region, 2015-2022 (USD Million)
Table 26 North America: Drug Discovery Informatics Market For Pharmaceutical And Biotechnology Companies, By Country, 2015-2022 (USD Million)
Table 27 Europe: Drug Discovery Informatics Market For Pharmaceutical And Biotechnology Companies, By Country, 2015-2022 (USD Million)
Table 28 Drug Discovery Informatics Market For Cros, By Region, 2015-2022 (USD Million)
Table 29 North America: Drug Discovery Informatics Market For Cros, By Country, 2015-2022 (USD Million)
Table 30 Europe: Drug Discovery Informatics Market For Cros, By Country, 2015-2022 (USD Million)
Table 31 Drug Discovery Informatics Market For Other End Users, By Region, 2015-2022 (USD Million)
Table 32 North America: Drug Discovery Informatics Market For Other End Users, By Country, 2015-2022 (USD Million)
Table 33 Europe: Drug Discovery Informatics Market For Other End Users, By Country, 2015-2022 (USD Million)
Table 34 Drug Discovery Informatics Market, By Region, 2015-2022 (USD Million)
Table 35 North America: Drug Discovery Informatics Market, By Country, 2015-2022 (USD Million)
Table 36 North America: Drug Discovery Informatics Market, By Function, 2015-2022 (USD Million)
Table 37 North America: Drug Discovery Informatics Market, By Solution, 2015-2022 (USD Million)
Table 38 North America: Drug Discovery Informatics Market, By End User, 2015-2022 (USD Million)
Table 39 Us: Drug Discovery Informatics Market, By Function, 2015-2022 (USD Million)
Table 40 Us: Drug Discovery Informatics Market, By Solution, 2015-2022 (USD Million)
Table 41 Us: Drug Discovery Informatics Market, By End User, 2015-2022 (USD Million)
Table 42 Canada: Drug Discovery Informatics Market, By Function, 2015-2022 (USD Million)
Table 43 Canada: Drug Discovery Informatics Market, By Solution, 2015-2022 (USD Million)
Table 44 Canada: Drug Discovery Informatics Market, By End User, 2015-2022 (USD Million)
Table 45 Europe: Drug Discovery Informatics Market, By Country, 2015-2022 (USD Million)
Table 46 Europe: Drug Discovery Informatics Market, By Function, 2015-2022 (USD Million)
Table 47 Europe: Drug Discovery Informatics Market, By Solution, 2015-2022 (USD Million)
Table 48 Europe: Drug Discovery Informatics Market, By End User, 2015-2022 (USD Million)
Table 49 Germany: Drug Discovery Informatics Market, By Function, 2015-2022 (USD Million)
Table 50 Germany: Drug Discovery Informatics Market, By Solution, 2015-2022 (USD Million)
Table 51 Germany: Drug Discovery Informatics Market, By End User, 2015-2022 (USD Million)
Table 52 Rest Of Europe: Drug Discovery Informatics Market, By Function, 2015-2022 (USD Million)
Table 53 Rest Of Europe: Drug Discovery Informatics Market, By Solution, 2015-2022 (USD Million)
Table 54 Rest Of Europe: Drug Discovery Informatics Market, By End User, 2015-2022 (USD Million)
Table 55 Asia Pacific: Drug Discovery Informatics Market, By Function, 2015-2022 (USD Million)
Table 56 Asia Pacific: Drug Discovery Informatics Market, By Solution, 2015-2022 (USD Million)
Table 57 Asia Pacific: Drug Discovery Informatics Market, By End User, 2015-2022 (USD Million)
Table 58 Row: Drug Discovery Informatics Market, By Function, 2015-2022 (USD Million)
Table 59 Row: Drug Discovery Informatics Market, By Solution, 2015-2022 (USD Million)
Table 60 Row: Drug Discovery Informatics Market, By End User, 2015-2022 (USD Million)
Table 61 Collaborations, Partnerships, Agreements, & Acquisitions, 2015-2017
Table 62 Expansions, 2015-2017
Table 63 Product Launches & Enhancements, 2015-2017

List of Figures
Figure 2 Breakdown Of Primary Interviews: By Company Type, Designation, And Region
Figure 3 Bottom Up Approach
Figure 4 Top Down Approach
Figure 6 Drug Discovery Informatics Market, By Function, 2017 Vs. 2022 (USD Billion)
Figure 7 Drug Discovery Informatics Market, By Solution, 2017 Vs. 2022 (USD Billion)
Figure 8 Drug Discovery Informatics Market, By End User, 2017 Vs. 2022 (USD Billion)
Figure 9 Geographical Snapshot Of Drug Discovery Informatics Market (2017-2022)
Figure 10 Rising Focus On Reducing Operational Costs-A Primary Growth Driver Of the Drug Discovery Informatics Market
Figure 11 Software Segment Will Continue To Dominate the Drug Discovery Informatics Market in 2022
Figure 12 APAC Will Be the Fastest-Growing Market From 2017 To 2022
Figure 13 Drug Discovery Informatics Market: Drivers, Restraints, & Opportunities
Figure 14 Global Pharmaceutical R&D Spending, 2012-2022 (USD Billion)
Figure 15 Drug Discovery Informatics Function
Figure 16 North America: Drug Discovery Informatics Market Snapshot
Figure 17 Asia Pacific: Drug Discovery Informatics Market Snapshot
Figure 18 Companies Adopted Product Launches, Expansions, Collaborations, Partnerships, Agreements, And Acquisitions As Their Key Growth Strategy Between 2014-2017
Figure 19 Jubilant Life Sciences: Company Snapshot (2017)
Figure 20 Ibm: Company Snapshot (2016)
Figure 21 Infosys: Company Snapshot (2016)
Figure 22 Thermo Fisher: Company Snapshot (2016)
Figure 23 Perkinelmer: Company Snapshot (2016)
Figure 24 Dassault Systèmes: Company Snapshot (2016)
Figure 25 Charles River Laboratories: Company Snapshot (2016)
Figure 26 Selvita: Company Snapshot (2016)

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Jubilant Life Sciences
  • IBM
  • Infosys
  • Thermo Fisher Scientific
  • Perkinelmer
  • Schrödinger
  • Dassault Systèmes
  • Charles River Laboratories
  • Selvita
  • Certara
  • Gvk Biosciences
  • Collaborative Drug Discovery
  • Openeye Scientific Software
  • IO Informatics
  • Novo Informatics
Note: Product cover images may vary from those shown
6 of 6
Note: Product cover images may vary from those shown
Adroll
adroll